Rare Diseases Clinical Trials in Mexico

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Rare Diseases Clinical Trials in Mexico

Rare Diseases Clinical Trials in Mexico – Clinical Trials LATAM

In the realm of medical research, clinical trials play a vital role in advancing our understanding of diseases and developing effective treatments. While the focus on rare diseases may be limited due to their low prevalence, they have a significant impact on individuals and their families.

Mexico, a country with a rich healthcare infrastructure, has made significant strides in conducting clinical trials for rare diseases. This blog post aims to shed light on the importance of rare diseases clinical trials in Mexico, highlighting the progress made, challenges faced, and the hope they bring to patients and their communities.

The Significance of Rare Diseases Clinical Trials

Rare diseases affect a small proportion of the population but collectively impact millions worldwide. These conditions often pose significant challenges for diagnosis, treatment, and research due to their limited knowledge and scarcity of available treatment options.

Clinical trials provide a ray of hope for individuals living with rare diseases and their families, as they offer the opportunity to explore new treatments, assess their efficacy, and gather valuable data to advance medical knowledge.

In recent years, Mexico has recognized the importance of rare diseases clinical trials and has made substantial efforts to enhance research and development in this field.

By conducting clinical trials, Mexico contributes to the global knowledge base, fosters collaboration with international researchers, and provides potential treatment options for patients who may have previously felt neglected by traditional healthcare systems.

Progress in Rare Diseases Clinical Trials in Mexico

Mexico has made remarkable progress in establishing a conducive environment for rare diseases clinical trials. The country has a robust regulatory framework that ensures patient safety and ethical considerations throughout the research process.

The Federal Commission for Protection against Health Risks (COFEPRIS) oversees clinical trials in Mexico and has implemented regulations that adhere to international standards, providing a level playing field for researchers and patients alike.

Collaboration between academia, research institutions, and pharmaceutical companies has been instrumental in driving the growth of rare diseases clinical trials in Mexico. Institutions such as the National Institute of Medical Sciences and Nutrition Salvador Zubirán and the National Institute of Pediatrics have been actively involved in research and clinical trials.

Furthermore, partnerships between Mexican organizations and global networks like the International Rare Diseases Research Consortium (IRDiRC) have facilitated knowledge exchange and access to resources, helping to accelerate progress.

The establishment of specialized centers of excellence for rare diseases has been a significant step forward. These centers serve as hubs for research, diagnosis, treatment, and patient support, allowing individuals with rare diseases to access specialized care and participate in clinical trials.

Additionally, the Mexican Rare Diseases Registry (REMER) has been pivotal in promoting research and facilitating collaboration among researchers, clinicians, and patients.

Rare Diseases Clinical Trials in Mexico

Rare Diseases Clinical Trials in Mexico

Challenges and Future Directions

Despite the advancements in rare diseases clinical trials in Mexico, several challenges persist. Limited awareness among the general public and healthcare professionals remains a significant barrier. Education and outreach efforts are necessary to improve understanding and encourage early diagnosis and participation in clinical trials.

Another challenge is the need for increased funding for rare diseases research. Government support and philanthropic initiatives can play a crucial role in driving research and development in this field. Greater investment in infrastructure, training programs for researchers, and specialized equipment can enhance the capabilities of research institutions and accelerate the discovery of new treatments.

Mexico can also benefit from strengthening international collaborations. By forging partnerships with global research networks, sharing expertise and resources, and participating in multi-country trials, Mexico can further expand its research capabilities and contribute to the development of innovative therapies for rare diseases.


Rare diseases pose unique challenges to individuals and healthcare systems worldwide. In Mexico, significant strides have been made in the field of rare diseases clinical trials, emphasizing the country’s commitment to improving the lives of those affected by these conditions.

Through a combination of regulatory frameworks, research institutions, specialized centers, and international collaborations, Mexico has established itself as a valuable player in the global landscape of rare diseases clinical trials.

Rare Diseases Clinical Trials in Mexico

Source: Roche

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Rare Diseases Clinical Trials in Mexico

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Rare Diseases Clinical Trials in Mexico

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Rare Diseases Clinical Trials in Mexico

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Rare Diseases Clinical Trials in Mexico

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Rare Diseases Clinical Trials in Mexico

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Rare Diseases Clinical Trials in Mexico

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Rare Diseases Clinical Trials in Mexico

The Cohortias Team

Rare Diseases Clinical Trials in Mexico

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Rare Diseases Clinical Trials in Mexico

Network & Partnerships